ADAGIO MEDICAL HOLDINGS INC (ADGM) Fundamental Analysis & Valuation

NASDAQ:ADGM • US00534B1008

Current stock price

1.03 USD
+0.13 (+14.41%)
At close:
1.0148 USD
-0.02 (-1.48%)
After Hours:

This ADGM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ADGM Profitability Analysis

1.1 Basic Checks

  • ADGM had negative earnings in the past year.
  • ADGM had a negative operating cash flow in the past year.
  • In the past 5 years ADGM reported 4 times negative net income.
  • ADGM had a negative operating cash flow in each of the past 5 years.
ADGM Yearly Net Income VS EBIT VS OCF VS FCFADGM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 -20M -40M -60M

1.2 Ratios

  • With a Return On Assets value of -57.99%, ADGM is not doing good in the industry: 71.12% of the companies in the same industry are doing better.
  • ADGM's Return On Equity of -202.26% is on the low side compared to the rest of the industry. ADGM is outperformed by 77.01% of its industry peers.
Industry RankSector Rank
ROA -57.99%
ROE -202.26%
ROIC N/A
ROA(3y)-249.67%
ROA(5y)-150.53%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ADGM Yearly ROA, ROE, ROICADGM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 -200 -400

1.3 Margins

  • ADGM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ADGM Yearly Profit, Operating, Gross MarginsADGM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 -2K -4K -6K -8K -10K

2

2. ADGM Health Analysis

2.1 Basic Checks

  • ADGM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ADGM has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ADGM has been increased compared to 5 years ago.
  • ADGM has a worse debt/assets ratio than last year.
ADGM Yearly Shares OutstandingADGM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
ADGM Yearly Total Debt VS Total AssetsADGM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of -3.98, we must say that ADGM is in the distress zone and has some risk of bankruptcy.
  • ADGM has a Altman-Z score of -3.98. This is in the lower half of the industry: ADGM underperforms 69.52% of its industry peers.
  • ADGM has a Debt/Equity ratio of 1.70. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 1.70, ADGM is not doing good in the industry: 82.89% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.7
Debt/FCF N/A
Altman-Z -3.98
ROIC/WACCN/A
WACC4.64%
ADGM Yearly LT Debt VS Equity VS FCFADGM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 50M 100M

2.3 Liquidity

  • ADGM has a Current Ratio of 2.44. This indicates that ADGM is financially healthy and has no problem in meeting its short term obligations.
  • With a Current ratio value of 2.44, ADGM perfoms like the industry average, outperforming 44.38% of the companies in the same industry.
  • ADGM has a Quick Ratio of 2.24. This indicates that ADGM is financially healthy and has no problem in meeting its short term obligations.
  • ADGM has a Quick ratio (2.24) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.44
Quick Ratio 2.24
ADGM Yearly Current Assets VS Current LiabilitesADGM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

0

3. ADGM Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 65.93% over the past year.
  • Looking at the last year, ADGM shows a very negative growth in Revenue. The Revenue has decreased by -100.00% in the last year.
EPS 1Y (TTM)65.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.09%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

  • Based on estimates for the next years, ADGM will show a very negative growth in Earnings Per Share. The EPS will decrease by -15.88% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y43.11%
EPS Next 2Y16.84%
EPS Next 3Y9.29%
EPS Next 5Y-15.88%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ADGM Yearly Revenue VS EstimatesADGM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2027 2028 2029 2030 10M 20M 30M 40M
ADGM Yearly EPS VS EstimatesADGM Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 2029 2030 -1 -2 -3

0

4. ADGM Valuation Analysis

4.1 Price/Earnings Ratio

  • ADGM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ADGM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ADGM Price Earnings VS Forward Price EarningsADGM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ADGM Per share dataADGM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.84%
EPS Next 3Y9.29%

0

5. ADGM Dividend Analysis

5.1 Amount

  • No dividends for ADGM!.
Industry RankSector Rank
Dividend Yield 0%

ADGM Fundamentals: All Metrics, Ratios and Statistics

ADAGIO MEDICAL HOLDINGS INC

NASDAQ:ADGM (5/1/2026, 8:08:30 PM)

After market: 1.0148 -0.02 (-1.48%)

1.03

+0.13 (+14.41%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Industry Strength11.18
Industry Growth59.01
Earnings (Last)03-27
Earnings (Next)05-14
Inst Owners30.93%
Inst Owner Change0.16%
Ins Owners3.31%
Ins Owner Change2.24%
Market Cap22.88M
Revenue(TTM)N/A
Net Income(TTM)-25.08M
Analysts82.86
Price Target3.57 (246.6%)
Short Float %0.44%
Short Ratio0.43
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-12.5%
PT rev (3m)-12.5%
EPS NQ rev (1m)-32.5%
EPS NQ rev (3m)-21.46%
EPS NY rev (1m)4.04%
EPS NY rev (3m)4.04%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.84
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.58
EYN/A
EPS(NY)-0.97
Fwd EYN/A
FCF(TTM)-0.87
FCFYN/A
OCF(TTM)-0.86
OCFYN/A
SpS0
BVpS0.56
TBVpS-0.38
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -57.99%
ROE -202.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-249.67%
ROA(5y)-150.53%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 1.7
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 38.56%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.44
Quick Ratio 2.24
Altman-Z -3.98
F-Score2
WACC4.64%
ROIC/WACCN/A
Cap/Depr(3y)73.79%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.09%
EPS Next Y43.11%
EPS Next 2Y16.84%
EPS Next 3Y9.29%
EPS Next 5Y-15.88%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y38.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year20.33%
EBIT Next 3Y-0.27%
EBIT Next 5YN/A
FCF growth 1Y37.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y35.46%
OCF growth 3YN/A
OCF growth 5YN/A

ADAGIO MEDICAL HOLDINGS INC / ADGM Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ADAGIO MEDICAL HOLDINGS INC (ADGM) stock?

ChartMill assigns a fundamental rating of 1 / 10 to ADGM.


Can you provide the valuation status for ADAGIO MEDICAL HOLDINGS INC?

ChartMill assigns a valuation rating of 0 / 10 to ADAGIO MEDICAL HOLDINGS INC (ADGM). This can be considered as Overvalued.


How profitable is ADAGIO MEDICAL HOLDINGS INC (ADGM) stock?

ADAGIO MEDICAL HOLDINGS INC (ADGM) has a profitability rating of 0 / 10.


How financially healthy is ADAGIO MEDICAL HOLDINGS INC?

The financial health rating of ADAGIO MEDICAL HOLDINGS INC (ADGM) is 2 / 10.